BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16091304)

  • 1. Preparation of enzymatically active recombinant class III protein deacetylases.
    North BJ; Schwer B; Ahuja N; Marshall B; Verdin E
    Methods; 2005 Aug; 36(4):338-45. PubMed ID: 16091304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.
    Du J; Jiang H; Lin H
    Biochemistry; 2009 Apr; 48(13):2878-90. PubMed ID: 19220062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro assays for the determination of histone deacetylase activity.
    Heltweg B; Trapp J; Jung M
    Methods; 2005 Aug; 36(4):332-7. PubMed ID: 16087348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
    Zhao K; Harshaw R; Chai X; Marmorstein R
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum Sir2: an unusual sirtuin with dual histone deacetylase and ADP-ribosyltransferase activity.
    Merrick CJ; Duraisingh MT
    Eukaryot Cell; 2007 Nov; 6(11):2081-91. PubMed ID: 17827348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins.
    Landry J; Slama JT; Sternglanz R
    Biochem Biophys Res Commun; 2000 Nov; 278(3):685-90. PubMed ID: 11095969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
    Sauve AA; Schramm VL
    Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity in the Sir2 family of protein deacetylases.
    Buck SW; Gallo CM; Smith JS
    J Leukoc Biol; 2004 Jun; 75(6):939-50. PubMed ID: 14742637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases.
    Marmorstein R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):904-9. PubMed ID: 15506920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.
    Vaquero A; Sternglanz R; Reinberg D
    Oncogene; 2007 Aug; 26(37):5505-20. PubMed ID: 17694090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assays for characterization of the Sir2 family of NAD(+)-dependent deacetylases.
    Borra MT; Denu JM
    Methods Enzymol; 2004; 376():171-87. PubMed ID: 14975305
    [No Abstract]   [Full Text] [Related]  

  • 14. Sirtuins (histone deacetylases III) in the cellular response to DNA damage--facts and hypotheses.
    Kruszewski M; Szumiel I
    DNA Repair (Amst); 2005 Nov; 4(11):1306-13. PubMed ID: 16084131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microplate filtration assay for nicotinamide release from NAD using a boronic acid resin.
    McDonagh T; Hixon J; DiStefano PS; Curtis R; Napper AD
    Methods; 2005 Aug; 36(4):346-50. PubMed ID: 16085423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
    Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
    Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule regulation of Sir2 protein deacetylases.
    Grubisha O; Smith BC; Denu JM
    FEBS J; 2005 Sep; 272(18):4607-16. PubMed ID: 16156783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin mechanism and inhibition: explored with N(ε)-acetyl-lysine analogs.
    Hirsch BM; Zheng W
    Mol Biosyst; 2011 Jan; 7(1):16-28. PubMed ID: 20842312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype selective substrates for histone deacetylases.
    Heltweg B; Dequiedt F; Marshall BL; Brauch C; Yoshida M; Nishino N; Verdin E; Jung M
    J Med Chem; 2004 Oct; 47(21):5235-43. PubMed ID: 15456267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
    Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
    ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.